Skip to main content

MediciNova, Inc. (MNOV)

NASDAQ: MNOV · Delayed Price · USD
3.62
-0.08 (-2.16%)
After-hours:Oct 21, 2021 6:11 PM EDT
3.70
-0.07 (-1.86%)
At close: Oct 21, 4:00 PM
Market Cap181.18M
Revenue (ttm)4.00M
Net Income (ttm)-11.16M
Shares Out48.80M
EPS (ttm)-0.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume70,119
Open3.77
Previous Close3.77
Day's Range3.63 - 3.80
52-Week Range3.33 - 10.81
Beta1.44
AnalystsStrong Buy
Price Target16.50 (+345.9%)
Est. Earnings DateOct 28, 2021

About MNOV

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction...

IndustryBiotechnology
IPO DateFeb 8, 2005
Employees9
Stock ExchangeNASDAQ
Ticker SymbolMNOV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for MediciNova stock is "Strong Buy." The 12-month stock price forecast is 16.50, which is an increase of 345.95% from the latest price.

Price Target
$16.50
(345.95% upside)
Analyst Consensus: Strong Buy

News

MediciNova Announces Abstract regarding the Mechanism by which MN-001 (tipelukast) Alters Triglyceride Metabolism Acc...

LA JOLLA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

1 day ago - GlobeNewsWire

MediciNova to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

LA JOLLA, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Cod...

1 month ago - GlobeNewsWire

MediciNova Announces MN-001 (tipelukast) Abstract regarding Lipid Metabolism in NASH/NAFLD Accepted for Presentation ...

LA JOLLA, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Cod...

1 month ago - GlobeNewsWire

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 32nd International Symposium on...

LA JOLLA, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

1 month ago - GlobeNewsWire

MediciNova Reports Second Quarter 2021 Financial Results and Business Update

Initiated preclinical animal studies for MN-166 as a treatment for chlorine gas-induced induced lung disease under partnership with BARDA

2 months ago - GlobeNewsWire

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Ophthalmic Di...

LA JOLLA, Calif., July 06, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

3 months ago - GlobeNewsWire

MediciNova to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

LA JOLLA, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

3 months ago - GlobeNewsWire

MediciNova To Test Ibudilast In BARDA's Validated Mouse Model Of Chlorine-Induced Pulmonary Injury

MediciNova Inc (NASDAQ: MNOV) will conduct a mouse study to investigate the efficacy of MN-166 (ibudilast) in a murine model of chlorine-induced lung injury and lethality.  After mice are exposed to chl...

3 months ago - Benzinga

MediciNova to Conduct Mouse Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeas...

LA JOLLA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

3 months ago - GlobeNewsWire

3 Top Biotech Stocks to Buy Right Now

These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.

Other symbols:AVXLTARS
3 months ago - The Motley Fool

Best Penny Stocks to Buy Right Now? 15 To Watch In July

These penny stocks are trending right now, here's why The post Best Penny Stocks to Buy Right Now? 15 To Watch In July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 months ago - PennyStocks

Top 10 Biotech Penny Stocks to Watch in July 2021

Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:ADILOPKVTVT
3 months ago - PennyStocks

MediciNov Sees Volume After Zacks Research Raises Price Target To $28

MediciNov Inc (NASDAQ: MNOV) sees a trading volume of 18.5 million shares after Zacks Small Cap Research increased the stock price target to $28 from $26.5 earlier. The research notes positive results f...

3 months ago - Benzinga

Hot Reddit Penny Stocks to Buy? 10 That You Should Know About

Looking for the top penny stocks on Reddit? Check these 10 out The post Hot Reddit Penny Stocks to Buy?

Other symbols:ANYBBIGGTERIG
4 months ago - PennyStocks

MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in N...

LA JOLLA, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

4 months ago - GlobeNewsWire

MediciNova to Participate in Maxim Group LLC Fireside Chat

LA JOLLA, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

4 months ago - GlobeNewsWire

MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasu...

LA JOLLA, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code...

4 months ago - GlobeNewsWire

MediciNova Reports First Quarter 2021 Financial Results and Business Update

- Completed $20M private placement financing with 3D Investment Partners -

5 months ago - GlobeNewsWire

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) an...

LA JOLLA, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code ...

5 months ago - GlobeNewsWire

MediciNova Receives Gene Therapy Milestone Payments

LA JOLLA, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Cod...

6 months ago - GlobeNewsWire

MediciNova to Participate in the B. Riley Neuroscience Conference

LA JOLLA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Cod...

6 months ago - GlobeNewsWire

MediciNova to Participate in the UBS Global Healthcare Virtual Conference

LA JOLLA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Cod...

6 months ago - GlobeNewsWire

What Will the Stock Market Do Today? 3 Big Stories to Watch.

So what will the stock market do today? It looks like investors will be closely watching the Roblox IPO and GE stock news.

Other symbols:RBLXSNDL
7 months ago - InvestorPlace

MNOV Stock: MediciNova Soars on Big BARDA Deal

MediciNova's MN-166 lung treatment is the first to get BARDA funding for repurposing research. MNOV stock double in Wednesday's premarket following that announcement.

7 months ago - InvestorPlace

Why MediciNova Shares Jumped 111% Today

MediciNova, Inc (NASDAQ: MNOV) shares soared 111% in the regular and after-hours sessions on Tuesday. What Happened: The biopharmaceutical company announced a partnership with the Biomedical Advanced Re...

7 months ago - Benzinga